Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 062
FDA updates list of recognized standards for medical devices, affecting compliance requirements for devices used in med-spas (e.g., lasers, injectables).
Aforeworn detected this change in the Med-Spa & Aesthetics Clinics space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Med-spa and aesthetics clinics using FDA-regulated devices (lasers, injectables, etc.) should confirm how it applies to their specific situation before acting. There is a time constraint attached: Ongoing; FDA expects compliance for new submissions immediately; existing devices may need updates by next renewal or inspection.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Med-Spa & Aesthetics Clinics continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FDA modified the list of recognized consensus standards; devices must meet updated standards for marketing clearance or may require re-evaluation.
Who it affects
Med-spa and aesthetics clinics using FDA-regulated devices (lasers, injectables, etc.)
What you must do
Review device inventory against updated standards list; ensure all devices comply with newly recognized standards.
Deadline
Ongoing; FDA expects compliance for new submissions immediately; existing devices may need updates by next renewal or inspection.
Never miss a change like this again
Aforeworn watches Med-Spa & Aesthetics Clinics around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Med-Spa & Aesthetics Clinics
- FDA Approves Labeling Changes for Over-the-Counter (OTC) Weight Loss Drug alli (Orlistat) to Warn of Risk of Kidney Stones and Kidney Injury
- Accolade Pacemaker Devices by Boston Scientific and Potential Need for Early Device Replacement - FDA Safety Communication
- Heart Pump Correction: Abiomed Issues Correction for Automated Impella Controllers
- Disruptions in Availability of Breast Biopsy Needles - Letter to Health Care Providers
- UPDATE: Hintermann Series H3 Total Ankle Replacement Has a Higher-Than-Expected Risk of Device Failure: FDA Safety Communication